-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The synthesis of natural products has long been a major focus in the chemical industry, with the goal of developing new drugs, fragrances, and other commercially valuable compounds.
However, with the increasing availability of genetic information and the rise of synthetic biology, the use of synthetic routes to natural products has become more commonplace.
One such example of this is the synthesis of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine, a compound with potential anticancer and anti-inflammatory properties.
The natural product (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine is derived from the marine sponge Geodia barretti, and has been shown to exhibit a range of biological activities, including the inhibition of cancer cell growth and the suppression of inflammation.
These properties make it an attractive target for the development of new drugs for the treatment of cancer and other diseases.
The synthesis of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine has been achieved through a variety of synthetic routes, with the most common method being via a sequence of chemical reactions known as the "Nitrile-Olefin Diels-Alder" reaction.
This reaction involves the formation of a cyclohexene ring, followed by the oxidation of the double bond to form a 2-cyclohexyloxy-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine, which is then reduced to give the desired (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine.
Another synthetic route to (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine involves the use of a Suzuki-Miyaura coupling reaction, which involves the formation of a carbon-carbon bond using a palladium catalyst.
This method has the advantage of avoiding the need for the oxidation step, and is therefore simpler and more efficient than the Nitrile-Olefin Diels-Alder reaction.
The development of synthetic routes to (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine has been a long and challenging process, with many failed attempts before successful syntheses were achieved.
However, the availability of genomic information for the marine sponge Geodia barretti has allowed for the biosynthesis of the natural product to be determined, providing valuable information for the development of synthetic routes.
The synthesis of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine has important implications for the development of new drugs and other commercially valuable compounds.
The natural product has shown promise in the treatment of cancer and inflammation, making it an attractive target for further research and development.
The synthesis of (12aR)-7-(hexyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]benzoxazepine via synthetic routes, such as the Nitrile-Olefin Diels-Alder reaction or the Suzuki-Miyaura coupling reaction, represents a significant step forward in the development of new drugs and other commercially valuable compounds from natural sources.